EUVIMEDEUVIMED entdecken
Open Access

Effects of Bacillus coagulans (GBI-30, 6086) supplementation on apparent total tract nutrient digestibility and the fecal characteristics and metabolites, immunity, and microbiota of healthy adult dogs

Sofia M Wilson iD, Yifei Kang, Jocelyn F Wren, John F Menton, Elena Vinay, Mathieu Millette, Melissa R Kelly, Zifan Xie iD, Michael J Miller, Kelly S Swanson iD

Journal of Animal Science · 04.01.2025 · 103

DOI: 10.1093/jas/skaf251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Animal Science, online erschienen am 16.08.2025. Verfasst von Sofia M Wilson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Sciences, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA. Hauptthemen laut MEDLINE: Bacillus coagulans, Digestion, Gastrointestinal Microbiome, Probiotics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Kerry Group.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacillus coagulans GBI-30, 6086, is a lactic acid-producing, spore-forming bacteria with diverse characteristics that lend it resiliency through commercial pet food processing, storage, and chemical and enzymatic digestion through the gastrointestinal tract. The objective of this study was to determine the effects of B. coagulans on dietary apparent total tract nutrient digestibility (ATTD) and the hematology, immunoglobulin concentrations and fecal characteristics, metabolites, and microbiota populations of healthy adult dogs. Adult English Pointer dogs (n = 12; age = 5.9 ± 2.5 yr; body weight = 26.6 ± 6.1 kg) were fed the same diet but supplemented with B. coagulans or a placebo via gelatin capsules in a replicated 3 × 3 Latin square design. Capsules were administered daily before each feeding, with the following treatments tested: (1) basal diet + placebo (control; 250 mg maltodextrin); (2) basal diet + B. coagulans [low dose; 5 × 108 colony-forming units (CFU)/d]; and (3) basal diet + B. coagulans (high dose; 2.5 × 109 CFU/d). Fecal, blood, nasal, and pinnae samples were collected after a 22-d adaptation phase in each period. Data were analyzed using the Mixed Models procedure of SAS 9.4, with P < 0.05 being significant and P < 0.10 being trends. Bacillus coagulans supplementation did not affect ATTD, food intake, fecal metabolites, immunoglobulin concentrations, or hematology, but did lower fecal scores (P < 0.05; firmer stool). Using qPCR, fecal Faecalibacterium spp. abundance was greater (P < 0.05) and fecal Bacteroides spp., Bifidobacterium spp., and Ruminococcus gnavus abundances tended to be greater (P < 0.10) in dogs fed the low B. coagulans dose than those fed the placebo. Overall, our results demonstrate that this bacterial species can be safely supplemented to healthy dogs without a negative impact on nutrient digestibility or canine health parameters, and supplementation with the low dose treatment may help maintain fecal consistency and positively influence gastrointestinal microbiota.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacillus coagulansDigestionGastrointestinal MicrobiomeProbioticsAnimalsDogsAnimal FeedAnimal Nutritional Physiological PhenomenaDietDietary SupplementsFeces

Stichwörter der Autor:innen

canine microbiotanutrient digestibilityprobiotic

Autor:innen und Institutionen

  • Department of Animal Sciences, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA.
  • The Carl R. Woese Institute for Genomic Biology, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA.
  • Kerry Group, Beloit, WI 53511, USA.
  • Kerry (Canada), Laval, Quebec H7V 4B3, Canada.
  • Science Made Simple, LLC, Winston Salem, NC 27101, USA.
  • Department of Food Science and Human Nutrition, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA.

ORCID-Profile: Sofia M Wilson, Zifan Xie, Kelly S Swanson

Förderung

  • Kerry Group

Zitieren

APA

Wilson, S. M., Kang, Y., Wren, J. F., Menton, J. F., Vinay, E., Millette, M., Kelly, M. R., Xie, Z., Miller, M. J., & Swanson, K. S. (2025). Effects of Bacillus coagulans (GBI-30, 6086) supplementation on apparent total tract nutrient digestibility and the fecal characteristics and metabolites, immunity, and microbiota of healthy adult dogs. Journal of Animal Science, 103. https://doi.org/10.1093/jas/skaf251

Vancouver

Wilson SM, Kang Y, Wren JF, Menton JF, Vinay E, Millette M, et al. Effects of Bacillus coagulans (GBI-30, 6086) supplementation on apparent total tract nutrient digestibility and the fecal characteristics and metabolites, immunity, and microbiota of healthy adult dogs. Journal of Animal Science. 2025;103. doi:10.1093/jas/skaf251

BibTeX
@article{Wilson2025,
  author = {Wilson, Sofia M and Kang, Yifei and Wren, Jocelyn F and Menton, John F and Vinay, Elena and Millette, Mathieu and Kelly, Melissa R and Xie, Zifan and Miller, Michael J and Swanson, Kelly S},
  title = {Effects of Bacillus coagulans (GBI-30, 6086) supplementation on apparent total tract nutrient digestibility and the fecal characteristics and metabolites, immunity, and microbiota of healthy adult dogs},
  journal = {Journal of Animal Science},
  year = {2025},
  volume = {103},
  doi = {10.1093/jas/skaf251}
}
Kostenlos starten →